Start here
One of the newer cousins of tretinoin, and gentler, so I reach for it in sensitive skin that cannot tolerate a retinoid. The downside is price. On the face alone, one tube lasts close to forever.
— Dr. Schwarz, Board Certified Dermatologist
Key Facts
−
| Also called | Aklief |
| Drug class | Topical retinoid, selective for the retinoic acid receptor gamma |
| Applied as | 0.005% cream, from a metered pump |
| Typical course | Long term |
| Time to work | 8 to 12 weeks |
| Prescription only | Yes |
What It Is
−
Trifarotene is a prescription retinoid cream, approved in 2019 for acne on the face, chest, back and shoulders from age nine up. Retinoids are vitamin A relatives that act on receptors inside skin cells; trifarotene targets mainly one of them, retinoic acid receptor gamma, the type most common in skin.
How It Works
−
Skin cells inside the pore stop shedding on schedule and form a plug. Trifarotene tells them to mature and shed normally, so the plug never builds. It also reduces inflammation and may fade the dark marks acne leaves.
The selective targeting gets sold as making it stronger. It really makes it more skin-specific, and head-to-head evidence against generic retinoids on the face is limited. What is different is that acne on the chest and back was studied and put on the label.
Acne treatments do not all do the same thing. Here is where Aklief acts, and what the others do instead.
Pick a treatment
Skin basics
Benzoyl peroxide releases oxygen inside the pore, and the bacteria involved in inflamed acne cannot live in it. It is the fastest of these on red, sore spots, and the one thing that stops acne bacteria becoming resistant to antibiotics.
Salicylic acid dissolves in oil, so it gets down inside the pore rather than sitting on the surface, and loosens the plug of dead skin and sebum blocking the way out. That suits blackheads and whiteheads more than deep, sore spots.
Retinoids change how the pore lining sheds, so plugs stop forming in the first place — which is why they prevent spots rather than treat the ones already there. Given months they also slow pigment reaching the surface and push fibroblasts to build collagen.
Azelaic acid does three things at once: loosens the plug in the pore, reduces the bacteria in it, and calms the pigment cells that leave a dark mark behind. That combination makes it useful on deeper skin tones, where the mark often outlasts the spot.
Niacinamide turns oil production down a little and interrupts pigment being handed to the cells above. The evidence for clearing spots is thin; it earns its place for the marks left behind, and for making stronger actives easier to tolerate.
Clindamycin is an antibiotic that quiets the bacteria in an inflamed pore. Used on its own it stops working within months as they adapt, so it is always paired with benzoyl peroxide or a retinoid.
Spironolactone blocks the hormone signal telling oil glands how much to make. It works on the pattern rather than the individual spot, over three to six months, which is why it suits deep jawline acne that flares with the cycle.
Isotretinoin shrinks the oil glands themselves, and much less oil means less of everything downstream: fewer plugs, fewer bacteria, less inflammation. It is the only acne treatment that often keeps working after the course ends.
The outer layer, and the only one anything in a jar reaches. It renews itself constantly: a cell made at the bottom takes about a month to reach the surface and flake off. Most of what a skincare product does, it does here.
The cells that make pigment. They sit along the base of the epidermis and hand melanin to the cells around them, which is what gives skin its colour. Dark marks, melasma and the patch left behind by a spot are all these cells making more than usual.
A narrow tube running from the surface down into the skin, with an oil gland at the bottom of it. Oil travels up and out. When the tube blocks, what is behind it has nowhere to go — which is where blackheads and spots start.
Makes sebum, the oil that keeps the surface soft and stops water escaping. How much it makes is set by hormones, not by how often you wash — which is why scrubbing does not fix oily skin.
Cutibacterium acnes lives in the pores of everyone with skin. It is not an infection and it is not a hygiene problem. It only causes trouble when a pore blocks and it multiplies in the oil trapped behind it.
The scaffolding in the dermis that keeps skin firm and springy. It is built by fibroblasts and broken down by age, sun and smoking. Lines and looseness are collagen lost faster than it is replaced.
The living layer underneath, holding the blood vessels, the nerves and the collagen. It is where lasting change happens and it is hard to reach: most of what is sold for the skin never gets this far.
What It Treats
−

Not the Best For
−



Forms
−
One product only, so there is no choice to make.

Strengths
−
One strength only.
Basics
−
Sample Routine
−
Here is where Aklief sits in a day, and what goes around it. Pick what you are treating and what your skin is like, and the rest of the routine changes to suit.
What to Expect
−
What to Avoid
−
- Sun and tanning beds Retinoids make skin burn more easily. Sunscreen on the face, and cover the trunk if you are treating it.
- Waxing and laser hair removal On treated skin, skin can lift off. Stop about a week beforehand.
- Scrubs, toners and strong acids Especially in the first month. They add irritation without benefit.
- Broken, raw or sunburnt skin Wait until it has healed.
Monitoring
−
No blood tests. Monitoring is a review at about twelve weeks to judge response and tolerance.
Nothing accumulates. What drifts is tolerance, and it usually improves rather than worsens. Once you are stable a yearly review is enough, and the recurring hassle is insurance renewal, not safety.
If You Stop
−
No rebound, no taper. Pores clog again at their old rate, and acne usually returns within two to three months. Many people switch to a cheaper generic retinoid for maintenance.
Cost
−
Brand only, no generic, and one of the more expensive topical acne treatments. Prior authorization is common, and insurers usually want a generic retinoid tried first. Manufacturer savings programs exist and change often.
Ask Your Doctor
−
How It Compares
−






Myths
+
- "Stronger means better results." Trifarotene is newer, not stronger. A retinoid you can use every night beats a stronger one your skin cannot tolerate.
- "Retinoids make acne worse." Some people flare in the first few weeks while skin turnover speeds up. It settles, and you judge the result at twelve weeks.
- "It cannot be used on the body." This is the retinoid trialled on the chest, shoulders and back, and approved for them as well as the face.
- "You cannot use it in summer." You can. It means daily sunscreen, which you should be using anyway.
- "You have to give up certain foods or alcohol." Nothing you eat or drink affects it. Very little reaches the bloodstream.
Questions Patients Ask
+
Is it better than tretinoin?
For the face, no strong evidence. For the chest and back, it is the retinoid with the label and the data.
Can I use it on my back myself?
Yes, but reach matters. A long-handled applicator helps; missing the middle of the back is the usual reason it seems not to work.
Why did my insurance refuse it?
Because generic retinoids exist, and most plans want one tried first.
Does the pump mean I am using the right amount?
It helps. One press per area, and more does not work faster.
References
+
- Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024. — American Academy of Dermatology, 2024
- Nast A, Al Wattar BH, Beylot Barry M, et al. Update of the EuroGuiDerm evidence-based guideline for the treatment of acne-Short version. Journal of the European Academy of Dermatology and Venereology : JEADV. 2026. — Journal of the European Academy of Dermatology and Venereology : JEADV, 2026
- Bell KA, Brumfiel CM, Haidari W, et al. Trifarotene for the Treatment of Facial and Truncal Acne. The Annals of pharmacotherapy. 2021. — The Annals of pharmacotherapy, 2021
- Blume-Peytavi U, Fowler J, Kemeny L, et al. Long-term safety and efficacy of trifarotene 50 ug/g cream, a first-in-class RAR-gamma selective topical retinoid, in patients with moderate facial and truncal acne. Journal of the European Academy of Dermatology and Venereology : JEADV. 2020. — Journal of the European Academy of Dermatology and Venereology : JEADV, 2020
- Alexis A, Del Rosso JQ, Forman S, et al. Importance of treating acne sequelae in skin of color: 6-month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne-induced post-inflammatory hyperpigmentation. International journal of dermatology. 2024. — International journal of dermatology, 2024
- Draelos ZD. Low irritation potential of tazarotene 0.045% lotion: Head-to-head comparison to adapalene 0.3% gel and trifarotene 0.005% cream in two studies. The Journal of dermatological treatment. 2023. — The Journal of dermatological treatment, 2023
